AMRI CEO to Present at Rodman & Renshaw Annual Global Investment Conference

ALBANY, New York, Aug. 31, 2012 /PRNewswire/ -- AMRI (NASDAQ: AMRI) announced today that AMRI Chairman, President and Chief Executive Officer Thomas E. D'Ambra, Ph.D. will present at the Rodman & Renshaw Annual Global Investment Conference on Monday, September 10, 2012 at 3:15 p.m. ET.

(Logo:  http://photos.prnewswire.com/prnh/20120229/NY61160LOGO)

A webcast of the corporate presentation will be available to investors and interested parties by accessing the company's website at www.amriglobal.com. This webcast will be archived for 90 days following the live presentation.

About AMRI

Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development, and manufacturing services. For over 21 years AMRI has demonstrated its adaptability as the pharmaceutical and biotechnology industries have undergone tremendous change in response to multiple challenges. This experience, a track record of success and locations in the United States, Europe and Asia now provides our customers with SMARTSOURCING™, a full range of value-added opportunities providing customers informed decision-making, enhanced efficiency and more successful outcomes at all stages of the pipeline. AMRI has also successfully partnered R&D programs and is actively seeking to out-license its remaining programs for further development.